Pendi, Asmihan .
HRN: 18-80-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/12/2025
10/19/2025
IV
375mg
Q6
Uti
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes